WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION

Mark Identification

Proof of use for OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION

We do not have any records of a proof of use for OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION at this moment.

Click here to add a proof of use for OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION

Possible trademark infringements of OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION

Basic Information about OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION

Serial Number
90533968
Filing Date
18 Feb 2021
Registration Number
7139722
Registration Date
15 Aug 2023
Mark Drawing Code
5

Classifications

Declare the trademark use of OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION on the blockchain with WikiTrademarks.io.

First use of OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION anywhere
OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION was first used on 31 Jul 2020 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
044
US Codes
100; 101

Who owns OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION?

1. Novartis AG Basel

2. Novartis AG Basel

3. Novartis AG Basel

Correspondent

Maury M. Tepper, III
TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH, NC 27609

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION